Patricia Redondo
Porto, 4200072, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Health and economic gains from bariatric surgery in Portugal: an in-depth analysis using a Markov model.
Journal: Health economics review
Published: July 16, 2025
Characterization of the Population, Treatment Patterns, and Outcomes of Patients with Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) with Epidermal Growth Factor Receptor Mutation (EGFRm): A Retrospective Cohort Study from IPO Porto.
Journal: Current oncology (Toronto, Ont.)
Published: June 05, 2025
CDK4/6 inhibitors and endocrine therapy in the treatment of metastatic breast cancer: A real-world and propensity score-adjusted comparison.
Journal: Cancer treatment and research communications
Published: January 24, 2024
Aggressiveness in systemic anticancer therapy at the end of life in an oncology center.
Journal: Porto biomedical journal
Published: November 25, 2023
Real‑world retrospective study of early‑stage prostate cancer at a Portuguese Comprehensive Cancer Centre: The PEarlC study.
Journal: Oncology letters
Published: November 07, 2023
Patient-Reported Outcomes and Experiences Assessment in Women with Breast Cancer: Portuguese Case Study.
Journal: International journal of environmental research and public health
Published: January 16, 2023
Costs, effectiveness, and safety associated with Chimeric Antigen Receptor (CAR) T-cell therapy: Results from a comprehensive cancer center.
Journal: PloS one
Published: June 28, 2022
Pertuzumab in Combination with Trastuzumab and Docetaxel in the Neoadjuvant Treatment for HER2-Positive Breast Cancer.
Journal: Journal of immunotherapy and precision oncology
Published: May 27, 2022
The addition of neoadjuvant pertuzumab for the treatment of HER2+ breast cancer: a cost estimate with real-world data.
Journal: Health economics review
Published: January 21, 2021
Small cell lung cancer treatment and survival in Portugal: A retrospective analysis from the I-O Optimise initiative.
Journal: European journal of cancer care
Published: November 05, 2020
Last Updated: 09/26/2026